Table 2.
Vital sign changes during the study period. SBP: Systolic Blood Pressure; DBP: Diastolic Blood Pressure; VAS: Visual Analogue Scale; POSAS: Patient and Observer Scar Assessment Scale
| Vital sign |
Placebo
(N = 32) |
Timolol
(N = 32) |
P -value | P -value ( repeated measure ANOVA) |
|---|---|---|---|---|
| SBP (mmHg) | 0.021 | |||
| Base line | 112.1 ± 9.7 | 111.2 ± 10.5 | 0.748 | |
| Day 1 | 112.8 ± 8.5 | 108.5 ± 10.4 | 0.097 | |
| Day 2 | 113.2 ± 9.8 | 106.7 ± 8.3 | 0.007 | |
| Day 3 | 111.5 ± 8.8 | 107.1 ± 10.1 | 0.065 | |
| Day 4 | 112.9 ± 9.4 | 107.8 ± 9.0 | 0.024 | |
| DBP (mmHg) | 0.070 | |||
| Base line | 70.4 ± 7.9 | 71.2 ± 9.0 | 0.883 | |
| Day 1 | 71.8 ± 7.8 | 68.5 ± 7.0 | 0.081 | |
| Day 2 | 72.1 ± 8.3 | 67.5 ± 7.1 | 0.021 | |
| Day 3 | 71.2 ± 7.5 | 67.5 ± 8.0 | 0.065 | |
| Day 4 | 72.1 ± 7.9 | 69.0 ± 6.8 | 0.089 | |
| Body Temperature (°C) | 0.188 | |||
| Base line | 37.1 ± 0.4 | 37.0 ± 0.4 | 0..888 | |
| Day 1 | 36.9 ± 0.3 | 36.8 ± 0.3 | 0.328 | |
| Day 2 | 36.9 ± 0.4 | 36.6 ± 0.3 | 0.002 | |
| Day 3 | 36.8 ± 0.3 | 36.8 ± 0.4 | 0.389 | |
| Day 4 | 36.7 ± 0.3 | 36.7 ± 0.3 | 0.388 | |
| Respiratory Rate (n/min) | 0.007 | |||
| Base line | 16.5 ± 2.9 | 17.7 ± 2.5 | 0.066 | |
| Day 1 | 17.9 ± 1.5 | 18.3 ± 0.8 | 0.091 | |
| Day 2 | 17.6 ± 1.2 | 18.4 ± 0.9 | 0.008 | |
| Day 3 | 17.3 ± 1.6 | 18.3 ± 0.6 | 0.006 | |
| Day 4 | 17.6 ± 1.2 | 18.2 ± 0.8 | 0.051 | |
| Heart Rate (n/min) | 0.716 | |||
| Base line | 79.3 ± 7.1 | 81.8 ± 4.5 | 0.050 | |
| Day 1 | 80 ± 4.0 | 78.4 ± 3.0 | 0.115 | |
| Day 2 | 79.9 ± 3.8 | 78.6 ± 2.2 | 0.089 | |
| Day 3 | 79.3 ± 3.5 | 79 ± 2.0 | 0.884 | |
| Day 4 | 79 ± 3.6 | 78.4 ± 2.0 | 0.514 | |